Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biomarkers for Cancer Treatment
Sponsor: University Hospitals Coventry and Warwickshire NHS Trust
Summary
Circulating biomarkers, such as miRNAs and proteomics, undergo identifiable and measurable changes during and following treatment for cancer, compared to pre-treatment baseline. Some of these changes may be associated either with known treatment parameters or predictive for cardiac or lung toxicity. The aim is to identify and validate changes following treatment for cancer, compared to pre-treatment baseline, as well as differential miRNA expression in two-group comparisons (patients receiving radical RT/chemoRT for thoracic cancers versus IO-based complex SACT).
Official title: Characterising Circulating Biomarker Signatures From Diverse Cancer Treatment Modalities - A Pilot Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
48
Start Date
2026-05-01
Completion Date
2028-04-30
Last Updated
2026-09-03
Healthy Volunteers
No
Conditions
Locations (1)
University Hospitals Coventry & Warwickshire NHS Trust
Coventry, United Kingdom